tiprankstipranks
Trending News
More News >
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market

Taysha Gene Therapies (TSHA) Income Statement

Compare
968 Followers

Taysha Gene Therapies Income Statement

Last quarter (Q4 2024), Taysha Gene Therapies's total revenue was $2.02M, a decrease of -43.90% from the same quarter last year. In Q4, Taysha Gene Therapies's net income was $-18.79M. See Taysha Gene Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 8.33M$ 15.45M$ 2.50M$ 0.00$ 0.00
Gross Profit
$ 8.33M$ 15.45M$ 15.00K$ -492.00K$ -9.00K
Operating Expenses
$ 99.79M$ 87.89M$ 128.53M$ 173.27M$ 43.00M
Depreciation and Amortization
$ 1.25M$ 1.37M$ 2.49M$ 492.00K$ 9.00K
EBITDA
$ -87.95M$ -105.20M$ -159.73M$ -172.78M$ -42.99M
Operating Income
$ -91.46M$ -72.44M$ -162.45M$ -173.27M$ -43.00M
Other Income/Expenses
$ 2.16M$ -39.13M$ -3.57M$ -1.26M$ -17.01M
Pretax Income
$ -89.30M$ -111.57M$ -166.01M$ -174.52M$ -60.01M
Net Income
$ -89.30M$ -111.57M$ -169.58M$ -175.46M$ -43.00M
Per Share Metrics
Basic EPS
$ -0.36$ -0.96$ -3.86$ -4.66$ -2.43
Diluted EPS
$ -0.36$ -0.96$ -3.86$ -4.66$ -2.43
Weighted Average Shares Outstanding
250.13M 232.24M 175.81M 150.60M 70.66M
Weighted Average Shares Outstanding (Diluted)
250.13M 232.24M 175.81M 150.60M 70.66M
Currency in USD

Taysha Gene Therapies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis